Researchers in Israel found that the use of medical cannabis reduced cancer patients’ pain and use of painkillers in a recently published study.
Bedrocan highlights SyqeAir’s TGA Approval in Australia
An article by Bedrocan about Syqe® receiving the Therapeutic Goods Administration (TGA) approval for the SyqeAir inhaler in Australia. This significant regulatory milestone is a step forward in the global expansion of our treatment.